Stocks · Health care · Pharmaceutical Preparations

BeOne Medicines Ltd.

ONC Clue Score63
Fiscal year ends December CIK 0001651308 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

By person

18 insiders · 16 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Xiaodong Wang
Director
—
$22.15M (16) scheduled
−$22.15M
4,588,163
$1.68B
−10.9%
Hhlr Advisors, Ltd. entity
10% owner
—
—
—
125,045,741
$45.79B
−12.5%
Baker Bros. Advisors LP entity
Director
—
—
—
16,662,655
$6.10B
−8.9%
John Oyler
Chief Executive Officer
—
—
—
5,697,649
$2.09B
—
Lai Wang
President, Global Head of R&D
—
—
—
1,710,085
$626.27M
+98.0%
Xiaobin Wu
President and COO
—
—
—
1,308,161
$479.08M
+75.5%
Aaron Rosenberg
Chief Financial Officer
—
—
—
397,891
$145.72M
+306.6%
Chan Henry Lee
SVP, General Counsel
—
—
—
311,324
$114.01M
+219.6%
Titus B. Ball
Principal Accounting Officer
—
—
—
97,929
$35.86M
+159.0%
Anthony C Hooper
Director
—
—
—
83,720
$30.66M
+55.7%
Margaret Dugan
Director
—
—
—
73,164
$26.79M
+68.5%
Alessandro Riva
Director
—
—
—
73,164
$26.79M
+68.5%
Corazon (Corsee) D. Sanders
Director
—
—
—
57,226
$20.96M
+23.2%
Olivier Brandicourt
Director
—
—
—
46,306
$16.96M
+183.4%
Shalini Sharp
Director
—
—
—
38,116
$13.96M
+367.6%
Qingqing Yi
Director
—
—
—
27,326
$10.01M
−40.8%
Charles Lazelle Sawyers
Director
—
—
—
18,984
$6.95M
+474,500%
Elizabeth Fisher Mooney
Director
—
—
—
18,980
$6.95M
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.